REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 59 filers reported holding REGULUS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,704,000 | -70.0% | 13,685,204 | 0.0% | 0.24% | -73.0% |
| Q2 2018 | $9,021,000 | -10.0% | 13,685,204 | -2.1% | 0.88% | -13.4% |
| Q1 2018 | $10,027,000 | -31.0% | 13,974,249 | 0.0% | 1.02% | -42.0% |
| Q4 2017 | $14,533,000 | -10.2% | 13,974,249 | +7.9% | 1.75% | -14.9% |
| Q3 2017 | $16,187,000 | +400.8% | 12,949,229 | +294.9% | 2.06% | +310.0% |
| Q2 2017 | $3,232,000 | +214.4% | 3,278,900 | +426.3% | 0.50% | +186.9% |
| Q1 2017 | $1,028,000 | -18.7% | 623,000 | +236.8% | 0.18% | -33.2% |
| Q3 2014 | $1,264,000 | -15.0% | 184,999 | 0.0% | 0.26% | +11.5% |
| Q2 2014 | $1,487,000 | -10.9% | 184,999 | 0.0% | 0.24% | -9.3% |
| Q1 2014 | $1,669,000 | -3.4% | 184,999 | -20.8% | 0.26% | -14.2% |
| Q4 2013 | $1,727,000 | -21.6% | 233,689 | 0.0% | 0.30% | -20.3% |
| Q3 2013 | $2,204,000 | -15.7% | 233,689 | -12.3% | 0.38% | -25.2% |
| Q2 2013 | $2,614,000 | – | 266,445 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|